Literature DB >> 12766125

Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes.

Michiaki Fukui1, Yoshihiro Kitagawa, Naoto Nakamura, Mayuko Kadono, Shinichi Mogami, Chizuko Hirata, Naoko Ichio, Katsuya Wada, Goji Hasegawa, Toshikazu Yoshikawa.   

Abstract

OBJECTIVE: There is evidence to suggest that low concentrations of testosterone are associated with an increased risk of cardiovascular disease in men. The aim of this study was to evaluate the relationship between serum testosterone concentration and carotid atherosclerosis as well as major cardiovascular risk factors in men with type 2 diabetes. RESEARCH DESIGN AND METHODS: Serum free and total testosterone concentrations were measured in 253 consecutive men with type 2 diabetes. The relationships between serum testosterone concentration and carotid atherosclerosis, determined by ultrasonographically evaluated intima-media thickness (IMT) and plaque score (PS) in a subgroup of 154 diabetic patients, as well as major cardiovascular risk factors, including age, blood pressure, and lipid concentrations, were evaluated.
RESULTS: Inverse correlations were found between free testosterone (F-tes) concentration and IMT (r = -0.206, P = 0.0103) and between F-tes concentration and PS (r = -0.334, P < 0.001). The IMT and PS were significantly greater in patients with lower concentrations of F-tes (<10 pg/ml) than in patients with higher concentrations of F-tes (1.01 +/- 0.29 vs. 0.91 +/- 0.26 mm, P = 0.038; 4.5 +/- 3.8 vs. 2.4 +/- 3.2, P = 0.0003; respectively). An inverse correlation was found between serum F-tes concentration and age (r = -0.420, P < 0.0001). A positive correlation was found between serum F-tes and total cholesterol concentrations (r = 0.145, P = 0.0238).
CONCLUSIONS: Serum F-tes concentration is inversely associated with carotid atherosclerosis determined by ultrasonographically evaluated IMT and PS in men with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766125     DOI: 10.2337/diacare.26.6.1869

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  21 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study.

Authors:  T Vikan; S H Johnsen; H Schirmer; I Njølstad; J Svartberg
Journal:  Eur J Epidemiol       Date:  2009-03-05       Impact factor: 8.082

3.  18β-Glycyrrhetinic Acid, a Novel Naturally Derived Agent, Suppresses Prolactin Hyperactivity and Reduces Antipsychotic-Induced Hyperprolactinemia in In Vitro and In Vivo Models.

Authors:  Di Wang; Yongfeng Zhang; Chunyue Wang; Dongxu Jia; Guangsheng Cai; Jiahui Lu; Di Wang; Zhang-Jin Zhang
Journal:  Neurochem Res       Date:  2016-05-09       Impact factor: 3.996

Review 4.  Gender differences in the cardiovascular effect of sex hormones.

Authors:  Cristiana Vitale; Michael E Mendelsohn; Giuseppe M C Rosano
Journal:  Nat Rev Cardiol       Date:  2009-06-30       Impact factor: 32.419

5.  Endogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular disease in the atherosclerosis risk in communities study.

Authors:  Reshmi Srinath; Sherita Hill Golden; Kathryn A Carson; Adrian Dobs
Journal:  J Clin Endocrinol Metab       Date:  2015-01-13       Impact factor: 5.958

Review 6.  The role of testosterone therapy in cardiovascular mortality: culprit or innocent bystander?

Authors:  Monique S Tanna; Arthur Schwartzbard; Jeffery S Berger; Joseph Alukal; Howard Weintraub
Journal:  Curr Atheroscler Rep       Date:  2015-03       Impact factor: 5.113

7.  Testosterone and the metabolic syndrome.

Authors:  Vakkat Muraleedharan; T Hugh Jones
Journal:  Ther Adv Endocrinol Metab       Date:  2010-10       Impact factor: 3.565

Review 8.  Hypogonadism and its treatment among prostate cancer survivors.

Authors:  Edward J Choi; Perry Xu; Farouk M El-Khatib; Linda M Huynh; Faysal A Yafi
Journal:  Int J Impot Res       Date:  2020-12-12       Impact factor: 2.896

9.  Inverse relationship between bioavailable testosterone and subclinical coronary artery calcification in non-obese Korean men.

Authors:  Byoung-Jin Park; Jae-Yong Shim; Yong-Jae Lee; Jung-Hyun Lee; Hye-Ree Lee
Journal:  Asian J Androl       Date:  2012-04-23       Impact factor: 3.285

10.  Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine.

Authors:  Darla L Tharp; Isabelle Masseau; Jan Ivey; Venkataseshu K Ganjam; Douglas K Bowles
Journal:  Cardiovasc Res       Date:  2009-01-30       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.